The effectiveness of the Jak inhibitor
A person in full social and working life. It is the often recurring profile of the patient with ulcerative colitis, a chronic disease characterized by inflammation of the mucous lining of the colon and rectum. The weight of this chronic inflammatory bowel disease (MICS) on the quality of life is in fact significant, both for the intermittent trend with remissions and exacerbations, and for the very nature of the symptoms, among which the most impacting is the rectal bleeding associated with diarrhea. If a metaphor could be found, it is like “an obnoxious travel companion who we hope always sleeps”, as stated by the director general Amici, National Association for Chronic Inflammatory Bowel Diseases, Salvatore Leone.
There are many good prospects: on the one hand, a communicative approach that leads to spreading the reality of this pathology … (Continue) read the 2nd page
Keywords | colitis, filgotinib, remission,